Advances in Cell and Gene Therapy for Rare Disease Treatment.

Area of Science:

• Biotechnology
• Pharmacology
• Medical Research

Background:

• Rare diseases affect small populations, often lacking effective treatments and facing research neglect due to low commercial viability.
• Government initiatives since the 1990s have spurred rare disease research and development, leading to market growth exceeding the broader pharmaceutical sector.

Purpose of the Study:

• To review orphan drug development within the rare disease market, focusing on advanced therapy medicinal products (ATMPs).
• To explore the strategic use of cell and gene therapies as ATMPs to boost the competitiveness of the orphan drug industry.

Main Methods:

• Literature review of orphan drug development trends.
• Analysis of advanced therapy medicinal products (ATMPs), specifically cell and gene therapies, in the rare disease context.

Main Results:

• The rare disease market is experiencing substantial growth, surpassing the overall pharmaceutical industry.
• Cell and gene therapies are leading categories within ATMPs for rare diseases, showing active development and clinical application.

Conclusions:

• ATMPs, particularly cell and gene therapies, offer significant opportunities for advancing rare disease treatments.
• Strategic utilization of these advanced therapies can enhance the competitiveness of the orphan drug industry.